RAP-536 alleviates anemia in Hbbth1/th1 mice and increases RBC numbers in wild-type mice
Group . | RBC (106 cells/µL) . | Hb (g/dL) . | Hct (%) . | MCV (fL) . | MCH (pg) . | MCHC (g/dL) . | Retic (%) . | RDWa (fL) . |
---|---|---|---|---|---|---|---|---|
Wild type + vehicle | 9.2 ± 0.1 | 13.7 ± 0.1 | 40.1 ± 0.5 | 43.5 ± 0.4 | 14.9 ± 0.1 | 34.4 ± 0.3 | 3.1 ± 0.1 | 28.8 ± 0.3 |
Wild type + RAP-536 | 10.5 ± 0.1* | 15.0 ± 0.2* | 43.4 ± 0.7* | 41.2 ± 0.4† | 14.2 ± 0.1* | 34.6 ± 0.3 | 3.1 ± 0.1 | 28.6 ± 0.2 |
Hbbth1/th1 + vehicle | 6.3 ± 0.2* | 9.0 ± 0.1* | 25.3 ± 0.6* | 40.2 ± 1.0† | 14.4 ± 0.6 | 35.7 ± 0.7 | 47.0 ± 5.8* | 41.8 ± 1.7* |
Hbbth1/th1 + RAP-536 | 8.1 ± 0.2‡ | 10.4 ± 0.2‡ | 30.0 ± 0.7‡ | 37.0 ± 0.6§ | 12.9 ± 0.4 | 34.9 ± 0.9 | 31.3 ± 2.2§ | 33.7 ± 1.3¶ |
Group . | RBC (106 cells/µL) . | Hb (g/dL) . | Hct (%) . | MCV (fL) . | MCH (pg) . | MCHC (g/dL) . | Retic (%) . | RDWa (fL) . |
---|---|---|---|---|---|---|---|---|
Wild type + vehicle | 9.2 ± 0.1 | 13.7 ± 0.1 | 40.1 ± 0.5 | 43.5 ± 0.4 | 14.9 ± 0.1 | 34.4 ± 0.3 | 3.1 ± 0.1 | 28.8 ± 0.3 |
Wild type + RAP-536 | 10.5 ± 0.1* | 15.0 ± 0.2* | 43.4 ± 0.7* | 41.2 ± 0.4† | 14.2 ± 0.1* | 34.6 ± 0.3 | 3.1 ± 0.1 | 28.6 ± 0.2 |
Hbbth1/th1 + vehicle | 6.3 ± 0.2* | 9.0 ± 0.1* | 25.3 ± 0.6* | 40.2 ± 1.0† | 14.4 ± 0.6 | 35.7 ± 0.7 | 47.0 ± 5.8* | 41.8 ± 1.7* |
Hbbth1/th1 + RAP-536 | 8.1 ± 0.2‡ | 10.4 ± 0.2‡ | 30.0 ± 0.7‡ | 37.0 ± 0.6§ | 12.9 ± 0.4 | 34.9 ± 0.9 | 31.3 ± 2.2§ | 33.7 ± 1.3¶ |
RBC parameters in β-thalassemic (Hbbth1/th1) mice and age-matched C57BL/6 wild-type mice treated with RAP-536 (1 mg/kg, s.c., twice weekly) or vehicle for 2 months starting at 3 months of age. Results are expressed as mean ± SEM (n = 12-17 mice per group). Hb, hemoglobin; Hct, hematocrit; MCV, mean cell volume; MCH, mean cell hemoglobin; MCHC, mean corpuscular hemoglobin concentration; Retic, reticulocytes.
P < .001 vs wild type + vehicle.
P < .01 vs wild type + vehicle.
P < .001 vs Hbbth1/th1 + vehicle.
P < .05 vs Hbbth1/th1 + vehicle.
P < .01 vs Hbbth1/th1 + vehicle.